Literature DB >> 6889941

A reproducible and stable model of acute ischaemic left ventricular failure in dogs.

O A Smiseth, O D Mjøs.   

Abstract

A model of acute ischaemic left ventricular (LV) failure is presented. In closed-chest anaesthetized dogs 50 micrometer plastic microspheres were injected repeatedly into the left main coronary artery over a period of about 40 min. The injections effected stepwise elevations of LV end-diastolic pressure (LVEDP). Thus, LVEDP could be increased to a desired level, about 20 mmHg, in a very controlled manner. All dogs developed signs of markedly depressed LV performance. Haemodynamic conditions stabilized about 60 min after embolization. The maximum LVDP/dt decreased from 2696 +/- 169 to 1823 +/- 98 mmHg . x-1, cardiac output decreased from 2.81 +/- 0.20 to 1.98 +/- 0.14 l . min-1 and mean aortic blood pressure decreased from 144 +/- 4 to 127 +/- 3 mmHg, while total peripheral resistance increased from 56 +/- 3 to 69 +/- 3 mmHg . l-1 . min. Myocardial blood flow decreased from 103 +/- 7 to 79 +/- 6 ml . min-1 . 100 g-1 and myocardial oxygen consumption decreased from 12.5 +/- 0.9 to 8.3 +/- 0.8 ml . min-1. 100 g-5. Myocardial uptake of lactate and free fatty acids decreased markedly. Electrocardiography showed signs of acute ischaemia. There were no deaths due to ventricular fibrillation. Morphological studies showed multiple small infarcts throughout the entire LV. In conclusion, repeated coronary embolization with 50 micrometers plastic microspheres, guided by the rise of LVEDP represents a simple and reproducible method for induction of uniform and stable acute LV failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889941     DOI: 10.1111/j.1475-097x.1982.tb00027.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  7 in total

1.  Apparent depression of right ventricular function after selective reduction of left ventricular inotropy: an interpretation of experimental data utilising a computer-based circulatory model.

Authors:  H Piene; O A Smiseth; H Refsum; J V Tyberg
Journal:  Med Biol Eng Comput       Date:  1983-09       Impact factor: 2.602

2.  The hemodynamic impact of diffuse myocardial ischemic lesions: an animal experimental model based on intracoronary microembolization.

Authors:  K Terp; W Y Kim; M Ulrich; J Frokiaer; U Baandrup; M Rehling; J P Bagger; J M Hasenkam
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 3.  Targeting Preload in Heart Failure: Splanchnic Nerve Blockade and Beyond.

Authors:  Marat Fudim; Muhammad Shahzeb Khan; Anousheh Awais Paracha; Kenji Sunagawa; Daniel Burkhoff
Journal:  Circ Heart Fail       Date:  2022-03-15       Impact factor: 8.790

Review 4.  Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.

Authors:  Marat Fudim; David M Kaye; Barry A Borlaug; Sanjiv J Shah; Stuart Rich; Navin K Kapur; Maria Rosa Costanzo; Michael I Brener; Kenji Sunagawa; Daniel Burkhoff
Journal:  J Am Coll Cardiol       Date:  2022-05-10       Impact factor: 27.203

5.  Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.

Authors:  B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

6.  Ibuprofen abolishes the increase in leucocyte chemiluminescence observed during ischemic myocardial failure, but fails to improve hemodynamic function.

Authors:  K Ytrehus; A G Semb; E S Myhre
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

7.  Proceedings of the 3rd annual Acute Cardiac Unloading and REcovery (A-CURE) symposium.

Authors:  Uma Chandrasekaran; Daniel Burkhoff; Kiyotake Ishikawa; Lija Swain; Kenji Sunagawa; Jacob Møller; Carlos Santos-Gallego; Shiva Annamalai; James Udelson; Ralf Westenfeld; Navin Kapur; Xiaoying Qiao; Julian Wiora; Andreas Schäfer; Alexander Bernhardt; Ajar Kochar; Robert Kloner; Haroon Faraz
Journal:  BMC Cardiovasc Disord       Date:  2019-02-07       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.